Clinical Utility of Liquid Biopsy to Detect BRAF and NRAS Mutations in Stage III/IV Melanoma Patients by Using Real-Time PCR.
Emilio Francesco GiuntaVincenzo De FalcoPietro Paolo VitielloLuigi Pio GuerreraGabriella SuaratoRossella NapolitanoAlessandra PerroneGiuseppe ArgenzianoRenato FrancoMichele CaragliaErika MartinelliDavide CiardielloFortunato CiardielloStefania NapolitanoTeresa TroianiPublished in: Cancers (2022)
Overall, our data suggest that qPCR-based ctDNA analysis could be informative in a subset of locally advanced and metastatic melanoma patients with specific clinical-radiological characteristics, supporting further investigations in this setting.
Keyphrases
- end stage renal disease
- real time pcr
- locally advanced
- newly diagnosed
- squamous cell carcinoma
- ejection fraction
- chronic kidney disease
- rectal cancer
- prognostic factors
- peritoneal dialysis
- radiation therapy
- neoadjuvant chemotherapy
- big data
- electronic health record
- patient reported outcomes
- ultrasound guided
- clinical trial
- open label
- patient reported
- study protocol
- circulating tumor